ALKBH5 and lung adenocarcinoma: Inhibition of RMRP in lung adenocarcinoma cell lines could achieve the same effects of ALKBH5 inhibition, including suppression of the abilities of cell proliferation, migration, and invasion, as well as promotion of apoptosis (165).